NEW YORK (GenomeWeb News) – GenMark Diagnostics reported after the close of the market on Tuesday that its revenues in the fourth quarter fell 31 percent year over year, but the company still beat the average Wall Street estimate on the top and bottom lines.

The Carlsbad, Calif.-based molecular diagnostics firm reported $6.5 million in total revenues for the three months ended Dec. 31, 2013, compared to $9.4 million in the year-ago fourth quarter and besting the consensus Wall Street estimate of $6.1 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more. 

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Jun
20
Sponsored by
PerkinElmer

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.